Why the study?
Does intranasal SK&F 40491 reduce viral shedding and antibody response in gibbons infected with human rhinovirus type 2?
Population
Gibbons infected with human rhinovirus type 2
Comparison
SK&F 40491 administered intranasally in a… vs Placebo
Design
Preclinical
Authors
Loading...
May support antiviral testing in rhinovirus models; hypothesis-generating and leaves open human translation.
Does intranasal SK&F 40491 reduce viral shedding and antibody response in gibbons infected with human rhinovirus type 2?
Intranasal administration of SK&F 40491 demonstrates antiviral activity against human rhinovirus type 2 in a gibbon model.
Pinto et al. (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: